U.S. market Closed. Opens in 2 hours 38 minutes

CABA | Cabaletta Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue1.43M3.68M733.00K354.00K104.00KN/A
Gross Profit-1.43M-3.68M-733.00K-354.00K-104.00KN/A
Operating Expenses74.66M54.14M46.31M33.83M18.68M6.19M
Selling, General & Admin19.24M14.84M13.82M12.46M7.01M1.73M
Research & Development55.42M39.30M32.49M21.38M11.67M4.47M
Other Operating ExpensesN/AN/AN/AN/AN/A-6.24M
Operating Income-74.66M-54.14M-46.31M-33.83M-18.68M-6.19M
Other Expenses / Income6.99M1.16M24.00K494.00K1.74M-6.24M
Before Tax Income-67.67M-52.98M-46.29M-33.34M-16.94M-12.20M
Income Tax ExpensesN/A-1.16M-757.00K-848.00K-1.84M-235.00K
Net Income-67.67M-51.81M-45.53M-32.49M-15.10M-12.20M
Interest ExpensesN/A-1.18MN/AN/AN/AN/A
Basic Shares Outstanding40.95M29.34M25.74M23.15M24.03M14.51M
Diluted Shares Outstanding40.95M29.34M25.74M23.15M24.03M14.51M
EBITDA-73.23M-54.14M-46.31M-33.83M-18.68M-6.19M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-67.67M-54.15M-46.29M-33.34M-16.94M-12.44M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙